More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...